Ashton, JR. Plans, hopes and ideas for mental health. BJPsych Bull
2017; 41: 3–6.
Mehta, N, Davies, SC. The importance of psychiatry in public mental health. Br J Psychiatry
2015; 207: 187–8.
Forsman, AK, Wahlbeck, K, Aaro, LE, Alonso, J, Barry, MM, Brunn, M, et al. Research priorities for public mental health in Europe: recommendations of the ROAMER project. Eur J Public Health
2015; 25: 249–54.
Akiyama, T. Profile of psychiatry in Japan. Int Psychiatry
2007; 4: 35–7.
Howes, OD, McCutcheon, R, Agid, O, de Bartolomeis, A, van Beveren, NJM, Birnbaum, ML, et al. Treatment-resistant schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology. Am J Psychiatry
2017; 174: 216–29.
Bennabi, D, Aouizerate, B, El-Hage, W, Doumy, O, Moliere, F, Courtet, P, et al. Risk factors for treatment resistance in unipolar depression: a systematic review. J Affect Disord
2015; 171: 137–41.
Post, RM. Heading off depressive illness evolution and progression to treatment resistance. Dialogues Clin Neurosci
2015; 17: 105–9.
Anderson, RJ, Hoy, KE, Daskalakis, ZJ, Fitzgerald, PB. Repetitive transcranial magnetic stimulation for treatment resistant depression: Re-establishing connections. Clin Neurophysiol
2016; 127: 3394–405.
Newton-Howes, G, Tyrer, P, Johnson, T. Personality disorder and the outcome of depression: meta-analysis of published studies. Br J Psychiatry
2006; 188: 13–20.
McGirr, A, Berlim, MT, Bond, DJ, Fleck, MP, Yatham, LN, Lam, RW. A systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials of ketamine in the rapid treatment of major depressive episodes. Psychol Med
2015; 45: 693–704.
Malhi, GS, Byrow, Y, Cassidy, F, Cipriani, A, Demyttenaere, K, Frye, MA, et al. Ketamine: stimulating antidepressant treatment?
2016; 2: e5–9.